Kuiwon Choi Selected Research

Kuiwon Choi Research Topics

Disease

42	Neoplasms (Cancer) 12/2016 - 03/2006
6	Osteoarthritis 09/2013 - 09/2008
2	Arthritis (Polyarthritis) 05/2014 - 12/2011
2	Rheumatoid Arthritis 06/2013 - 07/2010
2	Colonic Neoplasms (Colon Cancer) 09/2012 - 12/2009
2	Melanoma (Melanoma, Malignant) 02/2010 - 03/2006
1	Urinary Bladder Neoplasms (Bladder Cancer) 01/2016
1	Atherosclerosis 01/2015
1	Apnea 03/2014
1	Neoplasm Metastasis (Metastasis) 02/2014
1	Ischemia 09/2013
1	Peroneal Neuropathies 05/2013
1	Experimental Arthritis 12/2011
1	Phototoxic Dermatitis (Phototoxicity) 06/2011
1	Breast Neoplasms (Breast Cancer) 02/2010

Drug/Important Bio-Agent (IBA)

19	glycol-chitosanIBA 11/2016 - 10/2007
10	Matrix Metalloproteinases (MMPs)IBA 03/2014 - 09/2008
8	Drug CarriersIBA 11/2016 - 04/2008
7	Hyaluronic Acid (Hyaluronan)IBA 01/2015 - 03/2011
6	Peptides (Polypeptides)IBA 01/2016 - 04/2008
5	Photosensitizing Agents (Photosensitizers)IBA 09/2013 - 05/2009
4	Small Interfering RNA (siRNA)IBA 08/2014 - 02/2010
3	PolymersIBA 06/2014 - 10/2007
3	GoldIBA 06/2014 - 12/2010
3	Paclitaxel (Taxol)FDA LinkGeneric 12/2013 - 03/2006
3	EnzymesIBA 07/2013 - 12/2009
3	MicellesIBA 06/2012 - 02/2010
2	Contrast MediaIBA 05/2016 - 06/2014
2	CopperIBA 03/2014 - 11/2012
2	Cathepsin BIBA 02/2014 - 01/2012
2	1-phenyl-3,3-dimethyltriazene (PDT)IBA 09/2013 - 05/2011
2	Peptide Hydrolases (Proteases)FDA Link 06/2013 - 01/2012
2	Ethylene Glycol (Monoethylene Glycol)IBA 09/2012 - 02/2010
2	Proteins (Proteins, Gene)FDA Link 07/2012 - 07/2010
2	protoporphyrin IXIBA 06/2011 - 05/2009
2	Coloring Agents (Dyes)IBA 09/2010 - 02/2010
2	Antineoplastic Agents (Antineoplastics)IBA 09/2010 - 05/2009
2	CY5.5 cyanine dyeIBA 09/2010 - 10/2007
2	ChitosanIBA 09/2010 - 04/2010
2	AcidsIBA 07/2010 - 06/2010
2	cholanic acidIBA 04/2008 - 10/2007
1	GadoliniumIBA 05/2016
1	1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA 05/2016
1	AminesIBA 05/2016
1	ferric oxide (iron oxide)IBA 01/2016
1	Heparin (Liquaemin)FDA LinkGeneric 06/2014
1	AzidesIBA 03/2014
1	LigandsIBA 03/2014
1	SiliconesIBA 03/2014
1	Epidermal Growth Factor (EGF)IBA 12/2013
1	Monoclonal AntibodiesIBA 12/2013
1	ErbB Receptors (EGF Receptor)IBA 12/2013
1	pheophorbide aIBA 09/2013
1	Human Serum Albumin FDA LinkGeneric 09/2013
1	Aggrecans (Aggrecan)IBA 09/2013
1	DisulfidesIBA 09/2013
1	AlbuminsIBA 09/2013
1	Hyaluronoglucosaminidase (Hyaluronidase)FDA Link 07/2013
1	phytochlorinIBA 05/2012
1	Singlet OxygenIBA 05/2012
1	2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA 11/2011
1	Collagenases (Collagenase)FDA Link 11/2011
1	Matrix Metalloproteinase 13IBA 11/2011
1	Hyaluronan ReceptorsIBA 10/2011
1	CaspasesIBA 02/2011
1	Metalloproteases (Metalloproteinases)IBA 12/2010
1	Radioisotopes (Radionuclides)IBA 10/2010
1	Therapeutic UsesIBA 10/2010
1	PolyethyleneimineIBA 06/2010
1	monomethoxypolyethyleneglycol- polylactide block copolymerIBA 02/2010
1	monomethoxypolyethylene glycol (MPEG)IBA 02/2010
1	Ether (Diethyl Ether)IBA 02/2010
1	tetramethylrhodamine isothiocyanateIBA 02/2010
1	Doxorubicin (Adriamycin)FDA LinkGeneric 02/2010
1	poly(lactide) (polylactic acid)IBA 02/2010
1	poly(beta-amino ester)IBA 02/2010
1	Cisplatin (Platino)FDA LinkGeneric 04/2008
1	arginyl-glycyl-aspartic acidIBA 04/2008
1	IntegrinsIBA 04/2008
1	cremophor ELIBA 03/2006

Therapy/Procedure

19	Therapeutics 01/2016 - 04/2008
6	Intravenous Injections 05/2016 - 05/2012
3	Precision Medicine 12/2016 - 09/2012
3	Photochemotherapy (Photodynamic Therapy) 09/2013 - 05/2011
2	Intravenous Administration 12/2011 - 12/2009
1	Laparotomy 11/2016
1	RNAi Therapeutics 08/2014
1	Electrodes (Electrode) 05/2013
1	Lasers (Laser) 05/2012
1	Photothermal Therapy 12/2010
1	Osteotomy 10/2009